W 314 (Clopidogrel bisulfate 75 mg (base))

Pill imprint W 314 has been identified as Clopidogrel bisulfate 75 mg (base).

Clopidogrel is used in the treatment of ischemic stroke; ischemic stroke, prophylaxis; heart attack; peripheral arterial disease; acute coronary syndrome (and more), and belongs to the drug class platelet aggregation inhibitors. There is no proven risk in humans during pregnancy. Clopidogrel 75 mg (base) is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for W 314

Clopidogrel bisulfate 75 mg (base) W 314
Clopidogrel bisulfate
Imprint:
W 314
Strength:
75 mg (base)
Color:
Pink
Shape:
Round
Availability:
Prescription only
Drug Class:
Platelet aggregation inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Wockhardt Limited
National Drug Code (NDC):
55648-0314
Inactive Ingredients:
microcrystalline cellulose
ferric oxide red
glyceryl dibehenate
hydrogenated castor oil
hydroxypropyl cellulose
hypromellose 2910 (15 mPa.s)
lactose monohydrate
mannitol
polyethylene glycol 6000
titanium dioxide
triacetin

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)